Karin Schildermans

Karin Schildermans

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2018 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
EOEline Oeyen
Eline Oeyen
KMKurt Van Mol
Kurt Van Mol
GBGeert Baggerman
Geert Baggerman
HWHanny Willems
Hanny Willems
KBKurt Boonen
Kurt Boonen
IMInge Mertens
Inge Mertens
Extracellular vesicles (EVs) have a great potential in clinical applications. However, their isolation from different bodily fluids and their characterisation are currently not optimal or standardised. Here, we report the results of examining the performance of ultrafiltration combined with size exclusion chromatography (UF‐SEC) to isolate EVs from urine. The results reveal that UF‐SEC is an efficient method and provides high purity. Furthermore, we introduce asymmetrical‐flow field‐flow fractionation coupled with a UV detector and multi‐angle light‐scattering detector (AF4/UV‐MALS) as a characterisation method and compare it with current methods. We demonstrate that AF4/UV‐MALS is a straightforward and reproducible method for determining size, amount and purity of isolated urinary EVs.

28 May 2019 in Methods and Protocols
Verified
Journal Article
Open access
PDF file
EBEline Berghmans
Eline Berghmans
GRGeert Van Raemdonck
Geert Van Raemdonck
KSKarin Schildermans
Karin Schildermans
HWHanny Willems
Hanny Willems
KBKurt Boonen
Kurt Boonen
GBGeert Baggerman
Geert Baggerman
Advanced non-small-cell lung cancer (NSCLC) is generally linked with a poor prognosis and is one of the leading causes of cancer-related deaths worldwide. Since only a minority of the patients respond well to chemotherapy and/or targeted therapies, immunotherapy might be a valid alternative in the lung cancer treatment field, as immunotherapy attempts to strengthen the body’s own immune response to recognize and eliminate malignant tumor cells. However, positive response patterns to immunotherapy remain unclear. In this study, we demonstrate how immune-related factors could be visualized from single NSCLC tissue sections (Biobank@UZA) while retaining their spatial information by using matrix assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI), in order to unravel the molecular profile of NSCLC patients. In this way, different regions in lung cancerous tissues could be discriminated based on the molecular composition. In addition, we linked visualization (MALDI MSI) and identification (based on liquid chromatography higher resolution mass spectrometry) of the molecules of interest for the correct biological interpretation of the observed molecular differences within the area in which these molecules are detected. This is of major importance to fully understand the underlying molecular profile of the NSCLC tumor microenvironment.

7 November 2025 in Trends in Biotechnology
Verified
Journal Article
Closed access
PLPaula Maria Pincela Lins
Paula Maria Pincela Lins
DLDaphne Lintsen
Daphne Lintsen
SWSarah Willems
Sarah Willems
AMAmanda Elisa Moya-Gómez
Amanda Elisa Moya-Gómez
EPElke Pirlet
Elke Pirlet
Annelies BronckaersAnnelies Bronckaers
Annelies Bronckaers